Kite’s Yescarta yields positive results in ZUMA-1 trial in refractory large B-cell lymphoma

Kite’s Yescarta yields positive results in ZUMA-1 trial in refractory large B-cell lymphoma. Photo: courtesy of Philippe Delavie from Pixabay